Cannabis Bioscience International Holdings, Inc. (CBIH) Total Debt (2023 - 2026)

Cannabis Bioscience International Holdings has disclosed Total Debt across 4 years of filings, most recently posting $375813.0 for Q1 2026.

• In Q1 2026, Total Debt fell 3.35% year-over-year to $375813.0; the TTM figure through Feb 2026 stood at $375813.0 (down 3.35% YoY), while the FY2025 annual figure was $375814.0, down 4.28% from the prior year.
• Total Debt came in at $375813.0 for Q1 2026 at Cannabis Bioscience International Holdings, roughly flat from $375813.0 in the prior quarter.
• In the past five years, Total Debt ranged from a high of $412846.0 in Q4 2023 to a low of $369183.0 in Q3 2024.
• Average Total Debt over 4 years is $385160.4, with a median of $376721.0 recorded in 2024.
• The largest YoY upside for Total Debt was 1.84% in 2024 against a maximum downside of 8.75% in 2024.
• Over 4 years, Total Debt stood at $412846.0 in 2023, then slipped by 8.75% to $376721.0 in 2024, then retreated by 0.24% to $375813.0 in 2025, then changed by 0.0% to $375813.0 in 2026.
• Per Business Quant data, the three most recent Total Debt figures were $375813.0 in Q1 2026, $375813.0 in Q4 2025, and $375813.0 in Q3 2025.